gt20029
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 25, 2021 (NCT06468579)
Timeline
Indications
Mechanism of action
- Androgen ReceptorDEGRADER
androgen receptor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06692465 | Phase 2 | Apr 13, 2023 | Government of China, Suzhou Kintor Pharmaceutical Inc, |
| NCT05428449 | Phase 1 | Feb 10, 2022 | Suzhou Kintor Pharmaceutical Inc, |
| NCT06468579 | Phase 1 | Jul 25, 2021 | Suzhou Kintor Pharmaceutical Inc, |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Kintor Pharmaceutical Inc, | For profit | 3 | 3 | 2 | 2021 |
| Government of China | Government | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1